For your skin
The gold-standard fade ingredient for dark spots and melasma. Prescription-only and meant for short-term use under a dermatologist.
Want the science? Keep reading ↓Mechanism of action
Inhibits tyrosinase and is cytotoxic to melanocytes, suppressing melanin production.
Why we tier this strong
9 cited papers across 5 countries. Multiple positive efficacy results plus regulatory backing. Clears our published bar (Strong = 15+ studies with multiple randomized controlled trials (RCTs), or a single large longitudinal cohort).
Layering matrix
- Tretinoinmedium
Recognized depigmenting combination (Kligman formula) but increases sensitivity — physician oversight recommended.
Compare with
Cited research
Lima PB et al., Efficacy and safety of topical isobutylamido thiazolyl resorcinol (Thiamidol) vs. 4% hydroquinone cream for facial melasma: an evaluator-blinded RCT, JEADV 2021;35(9):1881-1887 — 4% hydroquinone produced melasma improvement equivalent to Thiamidol
McKesey J et al., Melasma Treatment: An Evidence-Based Review, American Journal of Clinical Dermatology 2020;21(2):173-225 — topical hydroquinone and triple combination remain superior first-line options for melasma
Petit A, Skin lightening and its motives: A historical overview, Annales de Dermatologie et de Venereologie 2019;146(5):399-409 — Hopital Saint-Louis AP-HP Paris historical review of skin-lightening practices including HQ use, safety profile, cultural drivers of cosmetic misuse
Kim GH, Cheong KA, Lee AY, Increased Skin Irritation by Hydroquinone and Retinoic Acid Used in Combination, Annals of Dermatology 2017;29(6):715-721 — HQ + retinoic acid combination significantly increases skin irritation vs either alone, in patch testing and keratinocyte assays
CIR Amended Safety Assessment of Hydroquinone as Used in Cosmetics, final amended report December 2014
Guerrero D, [Dermocosmetic management of hyperpigmentations], Annales de Dermatologie et de Venereologie 2012;139 Suppl 3:S115-S118 — French derm review of depigmenting strategies; HQ remains the Kligman-formula benchmark prescription agent but is restricted; dermocosmetic alternatives reviewed
Rajaratnam R et al., Interventions for melasma, Cochrane Database of Systematic Reviews 2010;7:CD003583 — triple combination, azelaic acid, and tretinoin showed efficacy; overall "available treatments inadequate"
Nordlund JJ et al., The safety of hydroquinone, Journal of the European Academy of Dermatology and Venereology 2006;20(7):781-7 — concluded strong safety record after 40-50 years of medical use
Guevara IL, Pandya AG, Safety and efficacy of 4% hydroquinone combined with 10% glycolic acid, antioxidants, and sunscreen in the treatment of melasma, International Journal of Dermatology 2003;42(12):966-972 — 4% HQ + glycolic + antioxidants was safe and effective for melasma
Sources: PubMed · KCI · J-Stage · CNKI · Wanfang · SFD · MFDS · Cochrane · SCCS · CIR. Every entry points to a specific document. See methodology for what each outcome label means.